Pancreatic Adenocarcinoma: Trends in Epidemiology, Risk Factors, and Outcomes
- PMID: 36154788
- PMCID: PMC10548451
- DOI: 10.1016/j.hoc.2022.07.002
Pancreatic Adenocarcinoma: Trends in Epidemiology, Risk Factors, and Outcomes
Abstract
Pancreatic cancer is one of the most lethal cancers in the world; it is a silent disease in which symptoms do not present until advanced stages, thereby reducing the 5-year survival rate to 10%. The global burden of pancreatic cancer has doubled over the past 25 years despite advancements in medicine. This review aims to discuss the global trends and disparities in pancreatic cancer, as well as the up-to-date literature on the known risk factors. A better understanding of these risk factors will reduce mortality by providing opportunities to screen these patients as well as counseling on lifestyle modifications.
Keywords: Epidemiology; Pancreatic Adenocarcinoma; Pancreatic cancer; Risk Factors; Trend.
Copyright © 2022 Elsevier Inc. All rights reserved.
Figures
References
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209–49. - PubMed
-
- Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncol 2016;55(9–10):1158–60. - PubMed
-
- Database SEER. Available at: https://seer.cancer.gov/statfacts/html/pancreas.html Web site. Accessed December 18, 2021.
-
- World Health Organization. Global cancer observatory. Available at: https://gco.iarc.fr/. Accessed January/9/21.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
